Operating
Stock-Based Comp
Insmed Stock-Based Comp increased by 17.2% to $45.75M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.5%, from $39.26M to $45.75M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 35.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Increasing levels may indicate a focus on talent retention but can also signal potential shareholder dilution.
Detailed definition
This represents the value of equity-based awards granted to employees as part of their total compensation package. Since...
Peer comparison
Standard across large-cap corporations; varies based on corporate compensation philosophy.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.74M | $12.23M | $11.52M | $12.82M | $14.26M | $15.65M | $14.95M | $16.44M | $18.36M | $19.99M | $19.98M | $21.45M | $23.29M | $25.55M | $26.55M | $39.26M | $42.98M | $31.43M | $39.04M | $45.75M |
| QoQ Change | — | +4.2% | -5.8% | +11.3% | +11.2% | +9.8% | -4.5% | +10.0% | +11.7% | +8.9% | -0.1% | +7.3% | +8.6% | +9.7% | +3.9% | +47.9% | +9.5% | -26.9% | +24.2% | +17.2% |
| YoY Change | — | — | — | — | +21.5% | +28.0% | +29.8% | +28.2% | +28.8% | +27.7% | +33.7% | +30.5% | +26.8% | +27.8% | +32.9% | +83.0% | +84.6% | +23.0% | +47.0% | +16.5% |
Range$11.52M – $45.75M
CAGR+33.2%
Avg YoY Growth+35.6%
Median YoY Growth+28.5%
Current Streak2 quarters growth
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Insmed's stock-based comp?
- Insmed (INSM) reported stock-based comp of $45.75M in Q1 2026.
- How has Insmed's stock-based comp changed year-over-year?
- Insmed's stock-based comp increased by 16.5% year-over-year, from $39.26M to $45.75M.
- What is the long-term trend for Insmed's stock-based comp?
- Over 4 years (2021 to 2025), Insmed's stock-based comp has grown at a 35.0% compound annual growth rate (CAGR), from $46.02M to $152.71M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock instead of cash.